Intas Pharmaceuticals Limited (manufacturing GLZ, primary and secondary packaging, quality control of batch; alternative manufacturer)

Ukraine

All drugs from this manufacturer

  • CISPLATIN ACCORD

    The drug is used to treat advanced or metastatic testicular, ovarian, bladder, non-small cell, and small cell lung cancer, as well as squamous cell carcinoma of the head and neck. It is also used for the treatment of cervical tumors in combination with other therapies.

    Dosage form: concentrate for infusion solution

    Active substance Dosage
    cisplatin 1 mg/ml

    ATC: L01XA01